CareDx, Inc. CDNA
Set alert
89.49 USD +3.61 +4.20%
As of Nov 3, 2:03 PM ET
85.44 Day range 90.05
14.27 52-week range 90.87
- YTD
- +375.00%
- 1 year
- +505.89%
- Open
- 85.63
- Prev close
- 85.88
- Mkt cap
- 4.70B
- Vol
- 1.00M
- Avg vol
- 1.30M
- EPS
- 2.37
- P/E
- 37.76
- Div yield
- 0.00%
More statistics
- Low
- 85.44
- High
- 90.05
- Forward P/E
- 55.95
- Beta
- 2.49
- Short ratio
- 4.56
- Inst. own
- 101.34%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 59.93
- 200-d avg
- 33.64
- 1y target
- 86.17
1M chart
Events in this range
- Oct 19, 2026Rating: Canaccord Genuity · Buy → Buy
- Oct 27, 2026Rating: BTIG · Buy → Buy
- Oct 29, 2026Earnings: 0.7; estimate 0.2548; surprise 174.73%
- Oct 30, 2026Rating: BTIG · Buy → Buy
Signals (9)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 86.17 -3.7% downside
Now 89.49
- Target (low)
- 46.00
- Target (mean)
- 86.17
- Target (high)
- 100.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
- Strong buy0
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.36333 | 0.31 – 0.41 | 0.12 | +202.8% | 135.95M | +25.4% | 6 |
| Next quarter | 0.30333 | 0.24 – 0.37 | 0.34 | -10.8% | 129.94M | +10.4% | 6 |
| Current year | 1.78 | 1.73 – 1.83 | 0.58 | +207.2% | 524.94M | +38.2% | 6 |
| Next year | 1.58 | 1.26 – 1.91 | 1.78 | -11.4% | 563.95M | +7.4% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 27, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 19, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 24, 2026 | BTIG | Maintained | Buy | Buy |
| Sep 2, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Aug 6, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 31, 2026 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Jul 16, 2026 | BTIG | Maintained | Buy | Buy |
| Apr 29, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 26, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 25, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Dec 15, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 6, 2025 | BTIG | Maintained | Buy | Buy |
| Sep 23, 2025 | BTIG | Reiterated | Buy | Buy |
| Sep 12, 2025 | BTIG | Reiterated | Buy | Buy |
| Aug 26, 2025 | William Blair | Initiated | — | Market Perform |
| Aug 8, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 18, 2025 | Craig-Hallum | Maintained | Buy | Buy |
| May 5, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 5, 2025 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Apr 17, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Mar 3, 2025 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| Feb 27, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Jan 15, 2025 | Wells Fargo | Upgrade | Underweight | Equal-Weight |
| Jan 14, 2025 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Nov 5, 2024 | BTIG | Maintained | Buy | Buy |
| Oct 22, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Oct 16, 2024 | Goldman Sachs | Maintained | Buy | Buy |
| Aug 27, 2024 | Wells Fargo | Initiated | — | Underweight |
| Aug 19, 2024 | BTIG | Upgrade | Neutral | Buy |